PIK3CA mutation status associated with improved tumor response to yttrium-90 radioembolization (Y90) of chemorefractory liver-dominant colorectal cancer (CRC) metastases

MLA

Elena N. Petre, et al. “PIK3CA Mutation Status Associated with Improved Tumor Response to Yttrium-90 Radioembolization (Y90) of Chemorefractory Liver-Dominant Colorectal Cancer (CRC) Metastases.” Journal of Vascular and Interventional Radiology, vol. 27, Mar. 2016, pp. S153–54. EBSCOhost, https://doi.org/10.1016/j.jvir.2015.12.399.

APA

Elena N. Petre, Constantinos T. Sofocleous, Franz E. Boas, Etay Ziv, Hooman Yarmohammadi, Kinh Gian Do, Joseph P. Erinjeri, Stephen B. Solomon, & M. Bergen. (2016). PIK3CA mutation status associated with improved tumor response to yttrium-90 radioembolization (Y90) of chemorefractory liver-dominant colorectal cancer (CRC) metastases. Journal of Vascular and Interventional Radiology, 27, S153–S154. https://doi.org/10.1016/j.jvir.2015.12.399

Chicago

Elena N. Petre, Constantinos T. Sofocleous, Franz E. Boas, Etay Ziv, Hooman Yarmohammadi, Kinh Gian Do, Joseph P. Erinjeri, Stephen B. Solomon, and M. Bergen. 2016. “PIK3CA Mutation Status Associated with Improved Tumor Response to Yttrium-90 Radioembolization (Y90) of Chemorefractory Liver-Dominant Colorectal Cancer (CRC) Metastases.” Journal of Vascular and Interventional Radiology 27 (March): S153–54. doi:10.1016/j.jvir.2015.12.399.